Get started
Author

Thomas Masetto

Observed names: Masetto, Thomas, T. Masetto
ORCID: 0000-0001-9609-3405
Observed ORCID: 0000-0001-9609-3405
OpenAlex ID: A5089512024
Evaluation of the necessity and the feasibility of the standardization of procalcitonin measurements: Activities of IFCC WG-PCT with involvement of all stakeholders
2021 · Huu-Hien Huynh, Amandine Bœuf, et al. · Clinica Chimica Acta · 31
Bioanalytical Performance of a New Particle-Enhanced Method for Measuring Procalcitonin
2020 · Anne Marie Dupuy, Anne Sophie Bargnoux, et al. · Diagnostics · 13
PDF
National external quality assessment and direct method comparison reflect crucial deviations of Procalcitonin measurements in Germany
2022 · Thomas Masetto, Abass Eidizadeh, et al. · Clinica Chimica Acta · 12
PDF
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection study
2022 · Jessica Brehm, Alexander Spaeth, et al. · Frontiers in Immunology · 6
PDF
Letter to the Editor regarding “Development of an antibody-free ID-LC MS method for the quantification of procalcitonin in human serum at sub-microgram per liter level using a peptide-based calibration”
2021 · Sebastian-Alexander Tölke, Thomas Masetto, et al. · Analytical and Bioanalytical Chemistry · 5
PDF
Comprehensive Comparison of the Capacity of Functionalized Sepharose, Magnetic Core, and Polystyrene Nanoparticles to Immuno-Precipitate Procalcitonin from Human Material for the Subsequent Quantification by LC-MS/MS
2023 · Thomas Masetto, Kai Matzenbach, et al. · International Journal of Molecular Sciences · 4
PDF
Characterization of the Diagnostic Performance of a Novel COVID-19 PETIA in Comparison to Four Routine N-, S- and RBD-Antigen Based Immunoassays
2021 · Alexander Spaeth, Thomas Masetto, et al. · Diagnostics · 4
PDF
Highly elevated sepsis biomarkers in advanced cholangiocarcinoma without sepsis: A case report and literature review
2025 · Bianca Karnuth, Almut Brundert, et al. · Medicine · 3
Immunoaffinity LC–MS/MS Quantification of the Sepsis Biomarker Procalcitonin Using Magnetic- and Polystyrene-Bead Immobilized Polyclonal Antibodies
2023 · Sebastian-Alexander Tölke, Thomas Masetto, et al. · Journal of Proteome Research · 3
Bioinformatical Design and Performance Evaluation of a Nucleocapsid- and an RBD-Based Particle Enhanced Turbidimetric Immunoassay (PETIA) to Quantify the Wild Type and Variants of Concern-Derived Immunoreactivity of SARS-CoV-2
2023 · Leoni Wey, Thomas Masetto, et al. · Biomedicines · 3
PDF
Vaccine-induced SARS-CoV-2 antibody response: the comparability of S1-specific binding assays depends on epitope and isotype discrimination
2023 · Silvia Schest, Claus Langer, et al. · Frontiers in Immunology · 1
PDF
A-216 510(k) clearance of the universally applicable DiaSys Procalcitonin FS test for the diagnosis of sepsis
2026 · Leoni Wey, Thomas Masetto, et al. · Clinical Chemistry
“Procalcitonin assay variation in an Australasian external quality assurance program”: A reappraisal
2026 · Thomas Masetto, Leoni Wey, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
Comment to: Extensive analytical evaluation of the performances of the new DiaSys PCT assay and comparison with Elecsys B·R·A·H·M·S PCT test on Roche Cobas and B·R·A·H·M·S PCT-sensitive Kryptor
2023 · Thomas Masetto, Matthias Grimmler · Clinical Chemistry and Laboratory Medicine (CCLM)
PDF
M079 Evaluation of a new accurate and reliable particle enhanced immunoturbidimetric assay for the detection of Procalcitonin in the management of sepsis
2022 · T. Masetto, C. Kochem, et al. · Clinica Chimica Acta
Works count: 16
Citation count: 85
H-index: 5
I10-index: 3
Year
Topic
Type